Guilisan, Sophia E.

HRN: 23-53-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/18/2026
03/25/2026
IV
680mg
Q6
URTI
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  URTIBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines